Biotoxtech Co Stock Current Liabilities
| 086040 Stock | KRW 5,600 50.00 0.88% |
Biotoxtech Co fundamentals help investors to digest information that contributes to Biotoxtech's financial success or failures. It also enables traders to predict the movement of Biotoxtech Stock. The fundamental analysis module provides a way to measure Biotoxtech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotoxtech stock.
Biotoxtech |
Biotoxtech Co Company Current Liabilities Analysis
Biotoxtech's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Biotoxtech Current Liabilities | 18.21 B |
Most of Biotoxtech's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotoxtech Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Biotoxtech Co has a Current Liabilities of 18.21 B. This is much higher than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The current liabilities for all Republic of Korea stocks is notably lower than that of the firm.
Biotoxtech Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotoxtech's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biotoxtech could also be used in its relative valuation, which is a method of valuing Biotoxtech by comparing valuation metrics of similar companies.Biotoxtech is currently under evaluation in current liabilities category among related companies.
Biotoxtech Fundamentals
| Return On Equity | 13.27 | |||
| Return On Asset | 0.0343 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 156.1 B | |||
| Shares Outstanding | 14.56 M | |||
| Shares Owned By Insiders | 26.95 % | |||
| Shares Owned By Institutions | 0.68 % | |||
| Price To Earning | 47.60 X | |||
| Price To Sales | 3.12 X | |||
| Revenue | 34.09 B | |||
| Gross Profit | 6.4 B | |||
| EBITDA | 5.67 B | |||
| Net Income | 6.98 B | |||
| Cash And Equivalents | 18.59 B | |||
| Cash Per Share | 803.72 X | |||
| Total Debt | 2.01 B | |||
| Debt To Equity | 47.30 % | |||
| Current Ratio | 0.71 X | |||
| Book Value Per Share | 1,604 X | |||
| Cash Flow From Operations | 4.35 B | |||
| Target Price | 15000.0 | |||
| Beta | 0.84 | |||
| Market Capitalization | 115.73 B | |||
| Total Asset | 90.74 B | |||
| Retained Earnings | (4.82 B) | |||
| Working Capital | (4.75 B) | |||
| Current Asset | 13.46 B | |||
| Current Liabilities | 18.21 B | |||
| Z Score | 34.2 | |||
| Net Asset | 90.74 B |
About Biotoxtech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotoxtech Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotoxtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotoxtech Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotoxtech Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Biotoxtech information on this page should be used as a complementary analysis to other Biotoxtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Biotoxtech Stock analysis
When running Biotoxtech's price analysis, check to measure Biotoxtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotoxtech is operating at the current time. Most of Biotoxtech's value examination focuses on studying past and present price action to predict the probability of Biotoxtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotoxtech's price. Additionally, you may evaluate how the addition of Biotoxtech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |